Your browser doesn't support javascript.
loading
Overall Survival Benefits of Cancer Drugs Approved in China From 2005 to 2020.
Zhang, Yichen; Naci, Huseyin; Wagner, Anita K; Xu, Ziyue; Yang, Yu; Zhu, Jun; Ji, Jiafu; Shi, Luwen; Guan, Xiaodong.
Afiliación
  • Zhang Y; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Naci H; LSE Health, Department of Health Policy, London School of Economics and Political Science, London, United Kingdom.
  • Wagner AK; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
  • Xu Z; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Yang Y; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Zhu J; Beijing Cancer Hospital, Beijing, China.
  • Ji J; Beijing Cancer Hospital, Beijing, China.
  • Shi L; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Guan X; International Research Centre for Medicinal Administration, Peking University, Beijing, China.
JAMA Netw Open ; 5(8): e2225973, 2022 08 01.
Article en En | MEDLINE | ID: mdl-35947385
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: JAMA Netw Open Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: JAMA Netw Open Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos